Pharmaceutical

Filter

Current filters:

None

Popular Filters

60 to 84 of 7017 results

Clinigen adds to oncology portfolio with AstraZeneca’s Ethyol

Clinigen adds to oncology portfolio with AstraZeneca’s Ethyol

20-08-2014

UK-based Clinigen Group has acquired the global rights to the oncology support therapy Ethyol (amifostine)…

ClinigenClinigen GroupEthyolLicensingOncologyPharmaceuticalTreatment for head and neck cancerUK

Depomed prevails in Gralise ANDA litigation with Actavis

Depomed prevails in Gralise ANDA litigation with Actavis

20-08-2014

US drug maker Depomed saw its shares climb more than 12% to $14.76 on Tuesday, on the news that the firm…

ActavisDepomedGraliseLegalNeurologicalPatentsPharmaceuticalUSA

Novartis to start production of Tasigna in Russia

Novartis to start production of Tasigna in Russia

19-08-2014

Russia’s largest drugmaker Pharmstandard has signed an agreement with Swiss pharma major Novartis on…

CancerCytokinesHealth Medical PharmaIgor KrylovMajorNovartisOncologyPharmaceuticalPharmstandardProductionRussiaTasigna

EXPERT VIEW: Pfizer and AstraZeneca, a marriage not to be – yet?

EXPERT VIEW: Pfizer and AstraZeneca, a marriage not to be – yet?

19-08-2014

Mergers and acquisitions may excite the markets and shareholders on both sides but their record of success…

GlobalInterviewsMergers & AcquisitionsPharmaceutical

Pfizer files palbociclib NDA with FDA for breast cancer

Pfizer files palbociclib NDA with FDA for breast cancer

19-08-2014

US pharma giant Pfizer says it has completed the submission of a New Drug Application to the US Food…

OncologypalbociclibPfizerPharmaceuticalRegulationUSA

Provectus opens negotiations on licensing PV-10 in China

Provectus opens negotiations on licensing PV-10 in China

19-08-2014

US developmental stage company Provectus Biopharmaceuticals has entered into a memorandum of understanding…

Breast cancerChinaLicensingMemorandum of understandingOncologyPharmaceuticalProvectus BiopharmaceuticalsPV-10Sinopharm

US DoJ closes investigation into AstraZeneca’s PLATO trial for Brilinta

US DoJ closes investigation into AstraZeneca’s PLATO trial for Brilinta

19-08-2014

Anglo-Swedish drug major AstraZeneca has received confirmation from the US Department of Justice that…

AstraZenecaBrilintaBrilintaCardio-vascularLegalPharmaceuticalUKUSA

Allergan names Jim Hindman chief financial officer

Allergan names Jim Hindman chief financial officer

19-08-2014

Allergy specialist Allergan has appointed Jim Hindman as chief financial officer, effective immediately,…

AllerganBoardroomBusiness FinanceBusiness FinanceChief financial officerJim HindmanPharmaceuticalUSA

Indian Health Ministry seeking compulsory license for B-MS’ Sprycel

Indian Health Ministry seeking compulsory license for B-MS’ Sprycel

19-08-2014

Anti-leukemia drug dasatinib, made by US pharma major Bristol-Myers Squibb and sold in India under the…

Bristol-Myers SquibbDasatinibIndiaOncologyPatentsPharmaceuticalSprycel

Basilea appoints David Veitch as chief commercial officer

Basilea appoints David Veitch as chief commercial officer

19-08-2014

Switzerland-based Basilea Pharmaceutica has appointed David Veitch as its chief commercial officer.

Basilea PharmaceuticaBoardroomPharmaceuticalSwitzerland

Ablynx receives $2.8 million grant to investigate nanobodies in eye disease treatment

Ablynx receives $2.8 million grant to investigate nanobodies in eye disease treatment

18-08-2014

Belgian drug developer Ablynx has received a 2.1 million euro ($2.8 million) grant from the Flemish Agency…

AblynxBelgiumOphthalmicsPharmaceuticalResearch

Proposal to expand the quality control of medicines sold in Brazil

Proposal to expand the quality control of medicines sold in Brazil

18-08-2014

Brazilian House Bill 6763/13 introduced by Gorete Pereira (PR-EC) sets the standards to ensure the quality…

BrazilPharmaceuticalProductionRegulation

Eisai files for US and EU approval of lenvatinib for hard to treat thyroid cancer

Eisai files for US and EU approval of lenvatinib for hard to treat thyroid cancer

18-08-2014

Japanese pharma major Eisai has filed applications with the US Food and Drug Administration and the European…

DonepezilEisaiEuropelenvatinibOncologyPharmaceuticalRegulationUSA

60 to 84 of 7017 results

Back to top